In a recent paper, Forrest [57] identified molecular targets and operations unique to cancer cells; in particular, the author, suggesting that ANT2 does import ATP into mitochondria of cancer cells, predicted that ANT2 is inversely orientated in the IMM compared to normal cells, making it resistant to inhibition by CAT and BKA, which are both inhibitors of ANT. Here, SLC25A6 is linked to cancer.